<?xml version="1.0" encoding="UTF-8"?>
<ref id="B82-vaccines-07-00045">
 <label>82.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pleguezuelos</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Robinson</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fern√°ndez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Stoloff</surname>
    <given-names>G.A.</given-names>
   </name>
   <name>
    <surname>Mann</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Gilbert</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Balaratnam</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Wilkinson</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Lambkin-Williams</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Oxford</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans</article-title>
  <source>Clin. Vaccine Immunol.</source>
  <year>2015</year>
  <volume>22</volume>
  <fpage>828</fpage>
  <lpage>835</lpage>
  <pub-id pub-id-type="doi">10.1128/CVI.00098-15</pub-id>
  <?supplied-pmid 25994549?>
  <pub-id pub-id-type="pmid">25994549</pub-id>
 </element-citation>
</ref>
